<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns="http://purl.org/rss/1.0/" xmlns:admin="http://webns.net/mvcb/">
<channel rdf:about="https://thescipub.com/">
<title>Most Viewed | Current Research in Drug Discovery</title>
<description>Most Viewed | Current Research in Drug Discovery</description>
<link>https://thescipub.com/crdd</link>
<admin:generatorAgent rdf:resource="https://thescipub.com/"/>
<admin:errorReportsTo rdf:resource="mailto:support@scipub.org"/>
<dc:publisher>Science Publications</dc:publisher>
<dc:language>en</dc:language>
<prism:publicationName>Science Publications</prism:publicationName>
<items>
<rdf:Seq>
<rdf:li rdf:resource="https://thescipub/abstract/crddsp.2014.26.28"/><rdf:li rdf:resource="https://thescipub/abstract/crddsp.2014.39.44"/><rdf:li rdf:resource="https://thescipub/abstract/crddsp.2014.17.25"/><rdf:li rdf:resource="https://thescipub/abstract/crddsp.2014.45.50"/><rdf:li rdf:resource="https://thescipub/abstract/crddsp.2014.29.38"/></rdf:Seq>
</items>
</channel><item rdf:about="https://thescipub/abstract/crddsp.2014.26.28">
    <title><![CDATA[Total Synthesis of Endangered Frog Alkaloid ’Epibatidine’, A Potent Analgesic of the Future]]></title>
    <link>https://thescipub/abstract/crddsp.2014.26.28</link>
    <content:encoded>
        <![CDATA[<p>Current Research in Drug Discovery, Published online: 26 January 2015; <a href="https://thescipub.com/abstract/crddsp.2014.26.28">doi:10.3844/crddsp.2014.26.28</a></p>’Epibatidine’ is a nicotinic alkaloid’, was first discovered in the skin of neotropical poisonous frog, ’Epipedobates tricolor’ found in Ecuador. John Daly in 1974 first isolated a trace q...]]></content:encoded>
    <dc:title><![CDATA[Total Synthesis of Endangered Frog Alkaloid ’Epibatidine’, A Potent Analgesic of the Future]]></dc:title><dc:creator>N.R.  Dhatrak</dc:creator><dc:creator>M.G.  Kulkarni</dc:creator><dc:identifier>doi:10.3844/crddsp.2014.26.28</dc:identifier>
    <dc:source>Current Research in Drug Discovery, Published online: 2015-01-26; | doi:10.3844/crddsp.2014.26.28</dc:source>
    <dc:date>2015-01-26</dc:date>
    <prism:publicationName>Science Publications</prism:publicationName>
    <prism:doi>10.3844/crddsp.2014.26.28</prism:doi>
    <prism:url>https://thescipub/abstract/crddsp.2014.26.28</prism:url>
    </item><item rdf:about="https://thescipub/abstract/crddsp.2014.39.44">
    <title><![CDATA[Reverse Pharmacology-A Paradigm Shift for Drug Discovery and Development]]></title>
    <link>https://thescipub/abstract/crddsp.2014.39.44</link>
    <content:encoded>
        <![CDATA[<p>Current Research in Drug Discovery, Published online: 26 January 2015; <a href="https://thescipub.com/abstract/crddsp.2014.39.44">doi:10.3844/crddsp.2014.39.44</a></p>The current scenario of drug discovery and development is facing a model perturbation, despite significant advances in genomics, proteomics, metabolomics, combinatorial chemistry and high through put ...]]></content:encoded>
    <dc:title><![CDATA[Reverse Pharmacology-A Paradigm Shift for Drug Discovery and Development]]></dc:title><dc:creator>Ashok D.B. Vaidya</dc:creator><dc:identifier>doi:10.3844/crddsp.2014.39.44</dc:identifier>
    <dc:source>Current Research in Drug Discovery, Published online: 2015-01-26; | doi:10.3844/crddsp.2014.39.44</dc:source>
    <dc:date>2015-01-26</dc:date>
    <prism:publicationName>Science Publications</prism:publicationName>
    <prism:doi>10.3844/crddsp.2014.39.44</prism:doi>
    <prism:url>https://thescipub/abstract/crddsp.2014.39.44</prism:url>
    </item><item rdf:about="https://thescipub/abstract/crddsp.2014.17.25">
    <title><![CDATA[CHITOSAN NANOPARTICLES AND THEIR APPLICATIONS IN DRUG DELIVERY: A REVIEW]]></title>
    <link>https://thescipub/abstract/crddsp.2014.17.25</link>
    <content:encoded>
        <![CDATA[<p>Current Research in Drug Discovery, Published online: 8 November 2014; <a href="https://thescipub.com/abstract/crddsp.2014.17.25">doi:10.3844/crddsp.2014.17.25</a></p>Chitosan is one of the most popular materials in the field of drug delivery due to its adhesivity and biodegradability. Different types of Chitosan based drug carriers have been conceived for various ...]]></content:encoded>
    <dc:title><![CDATA[CHITOSAN NANOPARTICLES AND THEIR APPLICATIONS IN DRUG DELIVERY: A REVIEW]]></dc:title><dc:creator>Sharare  Najafi</dc:creator><dc:creator>Zahra  Pazhouhnia</dc:creator><dc:creator>Omid  Ahmadi</dc:creator><dc:creator>Aydin  Berenjian</dc:creator><dc:creator>Hoda  Jafarizadeh-Malmiri</dc:creator><dc:identifier>doi:10.3844/crddsp.2014.17.25</dc:identifier>
    <dc:source>Current Research in Drug Discovery, Published online: 2014-11-08; | doi:10.3844/crddsp.2014.17.25</dc:source>
    <dc:date>2014-11-08</dc:date>
    <prism:publicationName>Science Publications</prism:publicationName>
    <prism:doi>10.3844/crddsp.2014.17.25</prism:doi>
    <prism:url>https://thescipub/abstract/crddsp.2014.17.25</prism:url>
    </item><item rdf:about="https://thescipub/abstract/crddsp.2014.45.50">
    <title><![CDATA[Design and Synthesis of Diaminotriazines as Anti-Tuberculosis DHFR Inhibitors]]></title>
    <link>https://thescipub/abstract/crddsp.2014.45.50</link>
    <content:encoded>
        <![CDATA[<p>Current Research in Drug Discovery, Published online: 26 January 2015; <a href="https://thescipub.com/abstract/crddsp.2014.45.50">doi:10.3844/crddsp.2014.45.50</a></p>A series of novel 2,4 diamino-s-triazine was designed as potential Mycobacterium tuberculosis (Mtb) Dihydro folate reductase inhibitors. The synthesized compounds were evaluated in whole cells by empl...]]></content:encoded>
    <dc:title><![CDATA[Design and Synthesis of Diaminotriazines as Anti-Tuberculosis DHFR Inhibitors]]></dc:title><dc:creator>Arundhati C Lele</dc:creator><dc:creator>Archana  Raju</dc:creator><dc:creator>M.K.  Ray</dc:creator><dc:creator>M.G.R.  Rajan</dc:creator><dc:creator>Mariam S Degani</dc:creator><dc:identifier>doi:10.3844/crddsp.2014.45.50</dc:identifier>
    <dc:source>Current Research in Drug Discovery, Published online: 2015-01-26; | doi:10.3844/crddsp.2014.45.50</dc:source>
    <dc:date>2015-01-26</dc:date>
    <prism:publicationName>Science Publications</prism:publicationName>
    <prism:doi>10.3844/crddsp.2014.45.50</prism:doi>
    <prism:url>https://thescipub/abstract/crddsp.2014.45.50</prism:url>
    </item><item rdf:about="https://thescipub/abstract/crddsp.2014.29.38">
    <title><![CDATA[Development and Optimization of Plant Extract Loaded Nanoemulsion Mixtures for the Treatment of Inflammatory Disorder]]></title>
    <link>https://thescipub/abstract/crddsp.2014.29.38</link>
    <content:encoded>
        <![CDATA[<p>Current Research in Drug Discovery, Published online: 26 January 2015; <a href="https://thescipub.com/abstract/crddsp.2014.29.38">doi:10.3844/crddsp.2014.29.38</a></p>In current study, a nanoemulsion as drug delivery system (NE) of spray dried Boswellia Serrata Extract (BSE) was developed and characterized to compare it in vitro/Ex vivo diffusion with reference for...]]></content:encoded>
    <dc:title><![CDATA[Development and Optimization of Plant Extract Loaded Nanoemulsion Mixtures for the Treatment of Inflammatory Disorder]]></dc:title><dc:creator>Mukesh  Gohel</dc:creator><dc:creator>Tejal  Soni</dc:creator><dc:creator>Lal  Hingorani</dc:creator><dc:creator>Asha  Patel</dc:creator><dc:creator>Nayan  Patel</dc:creator><dc:identifier>doi:10.3844/crddsp.2014.29.38</dc:identifier>
    <dc:source>Current Research in Drug Discovery, Published online: 2015-01-26; | doi:10.3844/crddsp.2014.29.38</dc:source>
    <dc:date>2015-01-26</dc:date>
    <prism:publicationName>Science Publications</prism:publicationName>
    <prism:doi>10.3844/crddsp.2014.29.38</prism:doi>
    <prism:url>https://thescipub/abstract/crddsp.2014.29.38</prism:url>
    </item></rdf:RDF>